Edesa Biotech, Inc.

EDSA · NASDAQ
Analyze with AI
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Assets
Cash & Equivalents$10,792$1,037$5,361$7,091
Short-Term Investments$0$0$0$0
Receivables$643$271$627$1,255
Inventory$0$0$0$0
Other Curr. Assets$78$367$449$746
Total Curr. Assets$11,513$1,676$6,437$9,092
Property Plant & Equip (Net)$0$18$100$31
Goodwill$0$0$0$0
Intangibles$1,978$2,079$2,180$2,281
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$40$41$173$171
Total NC Assets$2,018$2,138$2,454$2,484
Other Assets$0$0$0$0
Total Assets$13,531$3,814$8,890$11,576
Liabilities
Payables$0$1,813$1,747$2,122
Short-Term Debt$0$20$75$38
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0-$2,122
Other Curr. Liab.$1,079$0$0-$19
Total Curr. Liab.$1,079$1,833$1,822$2,141
LT Debt$0$0$20$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$131$126$0$0
Other NC Liab.$0$0$0$44
Total NC Liab.$131$126$20$44
Other Liabilities$0$0$0$0
Cap. Leases$0$20$94$19
Total Liabilities$1,210$1,833$1,842$2,184
Equity
Pref Stock$9,260$0$0$0
Common Stock$54,515$47,236$46,643$42,473
Retained Earnings-$65,911-$58,589-$52,419-$44,045
AOCI-$166-$243-$215-$214
Other Equity$14,753$13,577$13,039$11,176
Total Equity$12,452$1,981$7,049$9,391
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$13,662$3,814$8,890$11,576
Net Debt-$10,792-$1,017-$5,267-$7,053